Financials data is unavailable for this security.
View more
Year on year BlackRock Health Sciences Term Trust grew revenues 42.99% from 9.19m to 13.15m while net income improved from a loss of 682.72m to a gain of 69.86m.
| Gross margin | -65.26% |
|---|---|
| Net profit margin | -156.92% |
| Operating margin | -83.35% |
| Return on assets | -1.11% |
|---|---|
| Return on equity | -1.15% |
| Return on investment | -1.12% |
More ▼
Cash flow in USDView more
In 2023, BlackRock Health Sciences Term Trust increased its cash reserves by 1,165.70%, or 421.05k. The company earned 224.79m from its operations for a Cash Flow Margin of 1,709.95%. In addition the company used on investing activities and also paid 224.37m in financing cash flows.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 17.56 |
|---|---|
| Tangible book value per share | 17.56 |
More ▼
Balance sheet in USDView more
| Current ratio | -- |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | 0.00001 |
|---|---|
| Total debt/total capital | 0.00001 |
More ▼
Growth rates in USD
Year on year, growth in dividends per share fell -9.05% while earnings per share excluding extraordinary items rose 110.53%.
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -112.17 |
